Delivery Order SPE2D019D0003-SPE2D321F7646
Award Date 3/3/21
Potential Completion Date 3/8/21
Potential Value $26
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Horseheads, NY 14845, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order for rocuronium 10 mg/ml intravenous solution was awarded on March 3, 2021 by the Defense Logistics Agency Troop Support Medical to X-Gen Pharmaceuticals, Inc. of Horseheads, NY. The potential value of the contract is twenty-six dollars, with a completion date of March 8, 2021. The pricing type is firm fixed price for the delivery of the requested pharmaceutical product. No set-aside designation was used for this award to the prime contractor, X-Gen Pharmaceuticals, Inc. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 mL vials with a ceiling value of $1,228.60. This delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price pharmaceutical supply transaction performed in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded, reflecting the contractor's capability to meet federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Rocuronium 100 mg/10 ml vials totaling $1,166.98 under firm fixed pricing. This award represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 ml vials on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rocuronium is a neuromuscular blocking agent commonly used in anesthesia and critical care settings, making...
- This federal contract award, valued at $1,105.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX15D2223|SPE2DX25F4JPG) for the supply of 100 mg/10 mL vials of the drug Rocuronium, a muscle relaxant used in anesthesia. The contract has an ultimate completion date of May 1, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,187.44 to AmerisourceBergen Drug Corp for Rocuronium 100 mg/10 mL vials on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rocuronium is a neuromuscular blocking agent used in surgical and critical care settings,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 mL vials. This contract, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rocuronium is a neuromuscular blocking agent commonly...
- The Defense Logistics Agency awarded a delivery order valued at $1,859.18 to AmerisourceBergen Drug Corp for the supply of Rocuronium 50 mg/5 mL vials on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $218.96 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 mg/10 ml vials of rocuronium. The firm fixed price order is for 10 ml vials of the neuromuscular blocking drug to support Department of Defense requirements. Performance will take place in Conshohocken, Pennsylvania over one day in August 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Rocuronium 50 mg/5 ml vials. The $1,374.24 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...